Article Text

Download PDFPDF
Outcomes of gonioscopy-assisted transluminal trabeculotomy in advanced pigmentary glaucoma
  1. Arnav Panigrahi1,
  2. Anurag Kumar1,
  3. Shikha Gupta1,
  4. Davinder S Grover2,
  5. Viney Gupta1
  1. 1Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India
  2. 2Glaucoma Associates of Texas, Dallas, Texas, USA
  1. Correspondence to Dr Viney Gupta; gupta_v20032000{at}yahoo.com

Abstract

Purpose To compare outcomes of gonioscopy-assisted transluminal trabeculotomy (GATT) over a 12-month period with trabeculectomy in patients with advanced pigmentary glaucoma (PG).

Methods This was a pilot randomised controlled trial of patients with advanced PG (mean deviation worse than −12 dB), undergoing either GATT or a fornix-based trabeculectomy. Absolute success (criterion A) was defined as a postoperative intraocular pressure (IOP) between 6 and 18 mm Hg, with a drop of at least 30% from the treated preoperative value without need of any IOP-lowering medication. Success (criterion B) was also defined as per the target IOP, with an upper limit of 15 mm Hg for eyes with mean deviation (MD) between −12 and −24 dB, and 12 mm Hg or lower for MD values worse than −24 dB. Qualified success was a similar IOP standard on the same or fewer antiglaucoma medications.

Results For GATT (n=10), mean preoperative IOP and number of glaucoma medications were 28.2±11.2 mm Hg and 4±0.8 that reduced to 11.8±2.5 mm Hg and 0.7 at 12 months postoperatively, while in the trabeculectomy (n=12) group, they were 27.3±5.5 mm Hg and 3.6±0.7 that reduced to 11.5±2.2 mm Hg and 0.5±0.9, respectively. All eyes (100%) achieved qualified success. Absolute success was 60% and 67.7% by criterion A and 50% and 58.3% by criterion B for GATT and trabeculectomy, respectively. Two eyes in the trabeculectomy group developed hypotony while none of the GATT group had any sight-threatening complications (p=0.4).

Conclusions GATT alone demonstrated a significant reduction in IOP and number of glaucoma medications in patients with advanced PG.

  • glaucoma
  • angle

Data availability statement

Data are available upon reasonable request. Not Applicable.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

Data are available upon reasonable request. Not Applicable.

View Full Text

Footnotes

  • Contributors VG, AK, DSG and AP had substantial contribution to the conception and design of the study. AP, VG and AK had substantial contribution to the acquisition and collection of data. AP and VG contributed to the analysis and interpretation of data. AP, VG, DSG and SG contributed to the drafting of the manuscript. VG is the guarantor of this work.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.